Zalcitabine

Alternative names

AI838772, ALBU_HUMAN, AW493413, Albumin (32 AA), Albumin (AA 34), C-X-C chemokine receptor type 4, CD184, CD184 antigen, CXCR4_HUMAN, Chemokine (C X C motif) receptor 4, Chemokine CXC Motif Receptor 4, D2S201E, DKFZp779N1935, ERK-2, ERT1, Extracellular signal-regulated kinase 2, FB22, FLJ11090, Fusin, GIG20, GIG42, HM89, HSY3RR, LCR1, LESTR, Leukocyte-derived seven transmembrane domain receptor, Lipopolysaccharide associated protein 3, MAP kinase 1, MAP kinase 2, MAP kinase isoform p42, MAPK 1, MGC104252, MGC112732, MK01_HUMAN, Mitogen-activated protein kinase 1, Mitogen-activated protein kinase 2, NPY3R, NPYR, NPYRL, NPYY3, NPYY3R, Neuropeptide Y receptor Y3, OTTHUMP00000220436, OTTHUMP00000220438, OTTHUMP00000220439, P38, P41, PRKM 2, PRKM1, PRO0883, PRO0903, PRO1341, PRO1708, PRO2044, PRO2619, PRO2675, Probable G protein coupled receptor lcr1 homolog, RP24-311F12.2, SCAN1, SDF-1 receptor, SEVEN-TRANSMEMBRANE-SEGMENT RECEPTOR, Stromal cell-derived factor 1 receptor, TYDP, TYDP1_HUMAN, Tyr-DNA phosphodiesterase 1, Tyrosyl-DNA phosphodiesterase 1, UNQ696/PRO1341, WHIM, WHIMS, cell growth inhibiting protein 42, growth-inhibiting protein 20, p42-MAPK, protein kinase, mitogen-activated, 1, protein kinase, mitogen-activated, 2, protein tyrosine kinase ERK2